Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 1, 2012, Pages 110-119

  Dong, Le ^a   Li, Juan ^b   Liu, Yi ^a   Yue, Wenjie ^a   Luo, Xiaoting ^a  

^a FUDAN UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

Author keywords

Bifidobacteria; Dextran sulfate sodium induced colitis; Lactobacilli; Toll like receptor 2 monoclonal antibody; Toll like receptor 4 monoclonal antibody; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 4; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY; PROTEIN C JUN; TAB1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIACEAE; COLON MUCOSA; CONTROLLED STUDY; ESCHERICHIA COLI; FECES ANALYSIS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATION; LACTOBACILLUS; MICROBIOLOGICAL EXAMINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

EID: 84155174946     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06839.x     Document Type: Article

References (22)

1. Zhang SZ, Zhao XH, Zhang DC. Cellular and molecular immunopathogenesis of ulcerative colitis. Cell. Mol. Immunol. 2006; 3: 35-40.
2. Lemaitre B, Nicholas E, Michaut L etal. The dorso-ventral regulatory gene cassette spaetzle/Toll/Cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86: 973.
3. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394.
4. Toiyama Y, Araki T, Yoshiyama S etal. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative Ulcerative Colitis patients. Surg. Today 2006; 36: 287-90.
5. Heimesaat MM, Fischer A, Siegmund B etal. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via toll-like receptors 2 and 4. PLoS ONE 2007; 2: e662.
6. Farrell RJ, La Mont JT. Microbial factors in inflammatory bowel disease. Gastroenterol. Clin. North Am. 2002; 31: 41-62.
7. Oscar CTC, Jose M, Angel G. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin. Nutr. 2005; 24: 339-52.
8. Fedorak RN, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases. J. Clin. Gastroenterol. 2008; 42: 97-103.
9. Hart AL, Stagg AJ, Kamm MA. Use of probiotics in the treatment of inflammatory bowel disease. J. Clin. Gastroenterol. 2003; 36: 111-19.
10. Muzio M, Mantovani A. Toll-like receptors. Microbes Infect. 2000; 2: 251-5.
11. Dogi CA, Galdeano CM, Perdigon G. Gut immune stimulation by non pathogenic Gram(+) and Gram(-) bacteria. Comparison with a probiotic strain. Cytokine 2008; 41: 223-31.
12. O'Neill LAJ, Greene C. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 1998; 63: 650-7.
13. Baldwin AS Jr. Series introduction the transcription factor NF-κB and human disease. J. Clin. Invest. 2001; 107: 3-6.
14. Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 2001; 107: 7-11.
15. Waetzig GH, Seegert D, Rosenstiel P etal. P38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J. Immunol. 2002; 168: 5342-51.
16. Fuller R. Probiotics in man and animals. J. Appl. Bacteriol. 1989; 66: 365-78.
17. Cooper HS, Murthy SN, Shah RS etal. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993; 69: 238-49.
18. Liu Y, Zhang Z, Wang L etal. TLR4 monoclonal antibody blockade suppresses dextran-sulfate-sodium-induced colitis in mice. J. Gastroenterol. Hepatol. 2010; 25: 209-14.
19. Alex P, Zachos NC, Nguyen T etal. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 2009; 15: 341-52.
20. Fedorak RN. Understanding why probiotic therapies can be effective in treating IBD. J. Clin. Gastroenterol. 2008; 42: 111-15.
21. Kruis W, Fric P, Pokrotnieks J etal. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617-23.
22. Bibiloni R, Fedorak RN, Tannock GW etal. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 2005; 100: 1539-46.